Current population · 2,231
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hyp...
Brown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID...
← ExplorerSource ↗Publication identity
Publication IDCPD-1900
Year2023
PMID37348524
DOI10.1016/S2213-2600(23)00147-9
JournalLancet Respir Med
AuthorsBrown SM, Barkauskas CE, Grund B, Sharma S, Phillips AN, Leither L, Peltan ID...
First authorBrown SM
Senior authorLane HC; ACTIV-3b/Therapeutics for Severely Ill Inpatients with COVID-19 (TES...
Scientific classification
Research themeCOVID-19 / respiratory viruses; Clinical infectious diseases
Pathogen groupSARS-CoV-2
Technology / methodCulture / phenotypic methods; Clinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew Watts,
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/37348524/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →